Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.21 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 39.56.
Market Cap
8.21T
Revenue
4.52T
Profits
207.59B
PE Ratio
39.56
Profit Margin
4.59%
Dividend Yield
0.45%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 827.71B | -0.22% | 1,231,301 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 572.33B | -1.39% | 1,959,245 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 358.12B | -2.04% | 2,377,005 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 314.50B | -2.09% | 1,100,259 | 58.74B |
| 5 | NVS | Novartis AG | 294.55B | -2.04% | 1,019,225 | 56.67B |
| 6 | MRK | Merck & Co., Inc. | 288.48B | -3.45% | 2,877,810 | 65.01B |
| 7 | UNH | UnitedHealth Group Incorporated | 279.63B | 9.49% | 11,828,398 | 447.57B |
| 8 | AMGN | Amgen Inc. | 181.96B | -1.47% | 626,464 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 179.33B | -1.12% | 498,531 | 44.56B |
| 10 | ABT | Abbott Laboratories | 178.29B | 0.07% | 3,169,470 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 171.00B | -1.68% | 1,218,799 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 163.33B | -0.30% | 5,871,851 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 159.93B | -0.51% | 509,495 | 10.06B |
| 14 | PFE | Pfizer Inc. | 152.56B | -3.63% | 20,581,865 | 62.58B |
| 15 | DHR | Danaher Corporation | 134.02B | -1.43% | 710,856 | 24.57B |
| 16 | SYK | Stryker Corporation | 126.66B | -0.40% | 506,641 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 118.42B | -2.24% | 2,156,252 | 48.19B |
| 18 | SNY | Sanofi | 115.12B | -2.25% | 779,084 | 54.85B |
| 19 | GSK | GSK plc | 113.45B | -1.81% | 1,656,884 | 43.97B |
| 20 | MDT | Medtronic plc | 110.87B | 0.09% | 1,603,373 | 35.48B |
| 21 | VRTX | Vertex Pharmaceuticals Incorporated | 108.67B | -1.63% | 248,989 | 12.00B |
| 22 | HCA | HCA Healthcare, Inc. | 108.33B | 0.13% | 260,628 | 75.60B |
| 23 | MCK | McKesson Corporation | 104.43B | -0.49% | 213,265 | 397.96B |
| 24 | CVS | CVS Health Corporation | 99.41B | 6.63% | 7,219,499 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 91.18B | -1.98% | 5,020,007 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.95B | -1.73% | 146,328 | 14.34B |
| 27 | CI | The Cigna Group | 72.78B | 0.13% | 460,151 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 68.44B | 2.96% | 663,741 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.10B | -0.54% | 338,431 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 57.34B | -0.11% | 1,771,598 | 28.48B |
| 31 | MDLN | Medline Inc. | 57.25B | -0.68% | 1,059,345 | 28.43B |
| 32 | CAH | Cardinal Health, Inc. | 49.64B | -0.79% | 398,813 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.29B | -1.27% | 515,543 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 46.62B | -0.39% | 964,838 | 6.07B |
| 35 | ARGX | argenx SE | 46.37B | 0.42% | 163,789 | 4.24B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.50B | -1.05% | 161,156 | 4.30B |
| 37 | HLN | Haleon plc | 44.03B | -0.81% | 2,740,270 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 43.98B | -0.57% | 479,673 | 21.92B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.76B | -4.69% | 413,471 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.84B | -0.75% | 603,298 | 10.40B |
| 41 | INSM | Insmed Incorporated | 34.57B | -2.23% | 284,756 | 606.42M |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 34.19B | -1.54% | 1,416,142 | 17.26B |
| 43 | ONC | BeOne Medicines AG | 33.35B | -0.59% | 51,118 | 5.34B |
| 44 | RMD | ResMed Inc. | 32.37B | -0.78% | 160,354 | 5.40B |
| 45 | A | Agilent Technologies, Inc. | 32.10B | -1.11% | 182,546 | 7.07B |
| 46 | GEHC | GE HealthCare Technologies Inc. | 31.61B | -1.59% | 916,980 | 20.63B |
| 47 | WAT | Waters Corporation | 29.61B | -0.76% | 181,284 | 3.17B |
| 48 | NTRA | Natera, Inc. | 29.25B | 0.74% | 371,452 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 28.41B | -0.87% | 296,421 | 16.31B |
| 50 | VEEV | Veeva Systems Inc. | 27.89B | -2.24% | 380,183 | 3.20B |
| 51 | RPRX | Royalty Pharma plc | 26.90B | -1.47% | 671,971 | 2.38B |
| 52 | PHG | Koninklijke Philips N.V. | 25.90B | -1.36% | 667,719 | 20.94B |
| 53 | MTD | Mettler-Toledo International Inc. | 25.46B | -0.74% | 49,064 | 4.03B |
| 54 | BIIB | Biogen Inc. | 25.39B | 0.38% | 431,072 | 9.89B |
| 55 | UTHR | United Therapeutics Corporation | 24.55B | 0.10% | 199,390 | 3.18B |
| 56 | DXCM | DexCom, Inc. | 24.35B | 0.09% | 880,200 | 4.66B |
| 57 | HUM | Humana Inc. | 23.59B | 7.56% | 2,683,774 | 129.66B |
| 58 | LH | Labcorp Holdings Inc. | 22.35B | -1.17% | 85,923 | 13.95B |
| 59 | BNTX | BioNTech SE | 22.23B | -3.70% | 260,772 | 3.37B |
| 60 | DGX | Quest Diagnostics Incorporated | 22.02B | - | 217,917 | 11.04B |
| 61 | STE | STERIS plc | 21.40B | -0.83% | 96,436 | 5.83B |
| 62 | ROIV | Roivant Sciences Ltd. | 19.72B | -1.18% | 908,968 | 13.31M |
| 63 | ILMN | Illumina, Inc. | 19.34B | -0.96% | 231,047 | 4.34B |
| 64 | MRNA | Moderna, Inc. | 19.22B | -0.62% | 1,182,023 | 1.94B |
| 65 | RVMD | Revolution Medicines, Inc. | 18.72B | -0.96% | 318,837 | - |
| 66 | INCY | Incyte Corporation | 18.68B | -1.08% | 377,353 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.59B | 0.47% | 137,245 | 3.07B |
| 68 | CNC | Centene Corporation | 17.79B | 2.20% | 2,711,554 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 17.71B | 0.53% | 481,296 | 8.23B |
| 70 | HOLX | Hologic, Inc. | 16.97B | - | - | 4.13B |
| 71 | GMAB | Genmab A/S | 16.77B | -2.67% | 917,809 | 3.72B |
| 72 | THC | Tenet Healthcare Corporation | 16.70B | 0.94% | 188,963 | 21.31B |
| 73 | VTRS | Viatris Inc. | 15.27B | -1.08% | 6,800,240 | 14.30B |
| 74 | SMMT | Summit Therapeutics Inc. | 14.54B | 0.35% | 359,359 | - |
| 75 | PODD | Insulet Corporation | 14.41B | 0.58% | 254,915 | 2.71B |
| 76 | MEDP | Medpace Holdings, Inc. | 14.32B | 1.10% | 60,543 | 2.53B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.74B | -1.91% | 477,152 | 502.08M |
| 78 | SNN | Smith & Nephew plc | 13.65B | -3.13% | 1,105,616 | 6.16B |
| 79 | RGC | Regencell Bioscience Holdings Limited | 13.61B | -10.74% | 108,613 | - |
| 80 | ASND | Ascendis Pharma A/S | 13.50B | -2.95% | 183,268 | 845.52M |
| 81 | COO | The Cooper Companies, Inc. | 13.45B | -1.95% | 403,676 | 4.15B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.05B | -1.83% | 671,280 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 12.98B | 0.04% | 186,379 | 1.40B |
| 84 | GMED | Globus Medical, Inc. | 12.22B | 2.00% | 309,419 | 2.94B |
| 85 | FMS | Fresenius Medical Care AG | 12.07B | 0.62% | 147,376 | 23.05B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.03B | -1.99% | 437,243 | 943.71M |
| 87 | ALGN | Align Technology, Inc. | 11.87B | -3.12% | 224,580 | 4.03B |
| 88 | GH | Guardant Health, Inc. | 11.77B | 0.11% | 681,616 | 982.02M |
| 89 | ENSG | The Ensign Group, Inc. | 11.64B | 0.67% | 66,921 | 5.06B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.64B | -4.94% | 139,061 | 958.40M |
| 91 | JAZZ | Jazz Pharmaceuticals plc | 11.61B | 0.92% | 230,874 | 4.27B |
| 92 | EXEL | Exelixis, Inc. | 11.47B | 0.43% | 773,111 | 2.32B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.23B | -1.05% | 874,279 | 4.72B |
| 94 | UHS | Universal Health Services, Inc. | 11.08B | 0.02% | 104,104 | 17.36B |
| 95 | SOLV | Solventum Corporation | 10.86B | -1.03% | 218,995 | 8.33B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.74B | -0.66% | 333,271 | 3.22B |
| 97 | RDY | Dr. Reddy's Laboratories Limited | 10.71B | -1.64% | 614,640 | 3.85B |
| 98 | EHC | Encompass Health Corporation | 10.56B | 0.98% | 303,916 | 5.94B |
| 99 | DVA | DaVita Inc. | 10.02B | -0.01% | 151,603 | 13.64B |
| 100 | RVTY | Revvity, Inc. | 9.67B | -2.08% | 175,631 | 2.86B |
| 101 | MASI | Masimo Corporation | 9.31B | -0.06% | 287,612 | 1.53B |
| 102 | ABVX | ABIVAX Société Anonyme | 9.27B | -3.26% | 246,906 | 5.37M |
| 103 | BTSG | BrightSpring Health Services, Inc. | 8.89B | 0.16% | 590,383 | 12.91B |
| 104 | PCVX | Vaxcyte, Inc. | 8.59B | -0.25% | 390,867 | - |
| 105 | BAX | Baxter International Inc. | 8.53B | -0.72% | 1,070,883 | 11.24B |
| 106 | AXSM | Axsome Therapeutics, Inc. | 8.50B | -2.13% | 99,299 | 638.50M |
| 107 | HSIC | Henry Schein, Inc. | 8.45B | -1.56% | 173,919 | 13.18B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 8.42B | -2.50% | 89,737 | 7.46M |
| 109 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.39B | -1.98% | 338,252 | 1.09B |
| 110 | TECH | Bio-Techne Corporation | 8.32B | -1.21% | 1,096,834 | 1.22B |
| 111 | TEM | Tempus AI, Inc. | 8.30B | -1.80% | 1,397,981 | 1.27B |
| 112 | ICLR | ICON Public Limited Company | 8.25B | -1.50% | 111,601 | 8.10B |
| 113 | CRL | Charles River Laboratories International, Inc. | 8.21B | -0.82% | 143,560 | 4.02B |
| 114 | QGEN | Qiagen N.V. | 8.20B | -2.40% | 595,335 | 2.09B |
| 115 | NUVL | Nuvalent, Inc. | 8.00B | -1.85% | 145,422 | - |
| 116 | ATR | AptarGroup, Inc. | 7.97B | -0.78% | 93,451 | 3.78B |
| 117 | CYTK | Cytokinetics, Incorporated | 7.97B | -0.32% | 336,576 | 88.04M |
| 118 | KRYS | Krystal Biotech, Inc. | 7.67B | -0.51% | 73,946 | 389.13M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.52B | 0.62% | 318,096 | 1.40B |
| 120 | MOH | Molina Healthcare, Inc. | 7.52B | 0.63% | 558,876 | 43.56B |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 7.45B | -1.00% | 70,374 | 2.58B |
| 122 | IBRX | ImmunityBio, Inc. | 7.00B | -4.24% | 6,486,694 | 113.29M |
| 123 | HQY | HealthEquity, Inc. | 6.89B | -2.31% | 358,571 | 1.31B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.77B | -2.71% | 68,725 | 39.21M |
| 125 | GKOS | Glaukos Corporation | 6.74B | -0.43% | 182,980 | 507.44M |
| 126 | ACLX | Arcellx, Inc. | 6.74B | 0.07% | 461,897 | 22.29M |
| 127 | BLTE | Belite Bio, Inc | 6.63B | -1.47% | 33,780 | - |
| 128 | GRFS | Grifols, S.A. | 6.61B | -3.16% | 405,197 | 8.83B |
| 129 | RGEN | Repligen Corporation | 6.49B | -1.57% | 156,303 | 738.26M |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.48B | -1.27% | 119,501 | 46.02M |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.50% | 1,060,008 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.27% | 20,012,638 | - |
| 133 | APGE | Apogee Therapeutics, Inc. | 6.06B | -2.39% | 97,460 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.81B | -2.21% | 221,794 | 189.76M |
| 135 | MIRM | Mirum Pharmaceuticals, Inc. | 5.75B | -0.93% | 126,398 | 521.31M |
| 136 | CGON | CG Oncology, Inc. | 5.73B | 0.50% | 415,333 | 4.04M |
| 137 | PTCT | PTC Therapeutics, Inc. | 5.68B | -0.32% | 169,931 | 1.73B |
| 138 | BLCO | Bausch + Lomb Corporation | 5.65B | -2.45% | 118,296 | 5.10B |
| 139 | COGT | Cogent Biosciences, Inc. | 5.58B | -2.12% | 412,736 | - |
| 140 | SRRK | Scholar Rock Holding Corporation | 5.55B | -1.07% | 177,658 | - |
| 141 | BRKR | Bruker Corporation | 5.51B | -1.39% | 337,031 | 3.44B |
| 142 | CELC | Celcuity Inc. | 5.51B | -0.25% | 274,531 | - |
| 143 | ALKS | Alkermes plc | 5.42B | -4.37% | 591,261 | 1.48B |
| 144 | XENE | Xenon Pharmaceuticals Inc. | 5.41B | -0.28% | 117,388 | 7.50M |
| 145 | CHE | Chemed Corporation | 5.39B | 1.29% | 37,401 | 2.53B |
| 146 | AVTR | Avantor, Inc. | 5.34B | -1.00% | 2,182,904 | 6.55B |
| 147 | CAI | Caris Life Sciences, Inc. | 5.21B | -3.05% | 460,003 | 812.03M |
| 148 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | 0.15% | 1,877,679 | 1.00B |
| 149 | TFX | Teleflex Incorporated | 5.11B | 0.46% | 126,472 | 1.99B |
| 150 | PACS | PACS Group, Inc. | 5.08B | -0.77% | 195,710 | 5.29B |
| 151 | ERAS | Erasca, Inc. | 5.04B | -5.26% | 1,195,432 | - |
| 152 | LNTH | Lantheus Holdings, Inc. | 4.98B | 0.94% | 113,649 | 1.54B |
| 153 | TGTX | TG Therapeutics, Inc. | 4.92B | -1.07% | 332,285 | 616.29M |
| 154 | IMVT | Immunovant, Inc. | 4.91B | -3.01% | 302,984 | - |
| 155 | CRSP | CRISPR Therapeutics AG | 4.64B | -1.75% | 389,418 | 3.51M |
| 156 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.03% | 582,618 | 634.21M |
| 157 | ALHC | Alignment Healthcare, Inc. | 4.49B | 17.73% | 7,050,536 | 3.95B |
| 158 | DNTH | Dianthus Therapeutics, Inc. | 4.45B | -1.68% | 93,781 | 2.04M |
| 159 | HIMS | Hims & Hers Health, Inc. | 4.45B | -4.03% | 8,871,126 | 2.35B |
| 160 | WAY | Waystar Holding Corp. | 4.42B | -2.33% | 336,053 | 1.10B |
| 161 | OPCH | Option Care Health, Inc. | 4.36B | 0.47% | 304,895 | 5.65B |
| 162 | CORT | Corcept Therapeutics Incorporated | 4.33B | -0.32% | 262,135 | 761.41M |
| 163 | SHC | Sotera Health Company | 4.18B | -1.11% | 570,266 | 1.16B |
| 164 | RDNT | RadNet, Inc. | 4.17B | -2.36% | 107,488 | 2.04B |
| 165 | DOCS | Doximity, Inc. | 4.17B | -2.21% | 505,318 | 637.78M |
| 166 | NVST | Envista Holdings Corporation | 4.10B | -3.06% | 1,283,522 | 2.72B |
| 167 | MMSI | Merit Medical Systems, Inc. | 4.04B | 0.19% | 138,691 | 1.52B |
| 168 | LGND | Ligand Pharmaceuticals Incorporated | 4.00B | -1.54% | 64,089 | 268.09M |
| 169 | BLLN | BillionToOne, Inc. | 3.92B | -0.23% | 111,163 | 305.11M |
| 170 | SYRE | Spyre Therapeutics, Inc. | 3.89B | 1.02% | 194,795 | - |
| 171 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.89B | -1.56% | 873,142 | 7.70M |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 3.87B | -1.70% | 424,646 | 3.02B |
| 173 | OSCR | Oscar Health, Inc. | 3.84B | 1.18% | 3,002,175 | 11.70B |
| 174 | NAMS | NewAmsterdam Pharma Company N.V. | 3.83B | -2.40% | 399,537 | 22.50M |
| 175 | VKTX | Viking Therapeutics, Inc. | 3.82B | -2.98% | 618,499 | - |
| 176 | IRTC | iRhythm Holdings, Inc. | 3.77B | -0.56% | 75,205 | 747.14M |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 3.75B | -1.43% | 344,351 | 1.07B |
| 178 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.74B | -1.33% | 84,647 | 677.56M |
| 179 | STVN | Stevanato Group S.p.A. | 3.73B | -0.87% | 62,125 | 1.39B |
| 180 | TMDX | TransMedics Group, Inc. | 3.67B | 2.16% | 426,497 | 605.49M |
| 181 | GPCR | Structure Therapeutics Inc. | 3.65B | -0.52% | 305,518 | - |
| 182 | MMED | Minimed Group, Inc. | 3.64B | -1.97% | 310,787 | 2.89B |
| 183 | LIVN | LivaNova PLC | 3.45B | -0.61% | 174,009 | 1.39B |
| 184 | EWTX | Edgewise Therapeutics, Inc. | 3.41B | -3.11% | 211,590 | - |
| 185 | LEGN | Legend Biotech Corporation | 3.30B | -4.55% | 537,751 | 1.03B |
| 186 | BKD | Brookdale Senior Living Inc. | 3.27B | -0.97% | 350,948 | 3.05B |
| 187 | LQDA | Liquidia Corporation | 3.26B | -1.67% | 254,259 | 158.32M |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.18B | 4.84% | 124,550 | 803.79M |
| 189 | HNGE | Hinge Health, Inc. | 3.05B | -1.17% | 202,708 | 587.86M |
| 190 | TWST | Twist Bioscience Corporation | 3.05B | -2.79% | 297,067 | 391.56M |
| 191 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | -0.06% | 501,381 | 588.99M |
| 192 | ICUI | ICU Medical, Inc. | 3.03B | -1.28% | 38,051 | 2.23B |
| 193 | DNLI | Denali Therapeutics Inc. | 3.00B | -2.43% | 468,662 | - |
| 194 | TVTX | Travere Therapeutics, Inc. | 2.95B | 0.50% | 567,806 | 490.73M |
| 195 | DYN | Dyne Therapeutics, Inc. | 2.94B | -2.78% | 262,519 | - |
| 196 | ITGR | Integer Holdings Corporation | 2.93B | -0.48% | 64,921 | 1.85B |
| 197 | TARS | Tarsus Pharmaceuticals, Inc. | 2.92B | -2.15% | 61,998 | 451.36M |
| 198 | ARQT | Arcutis Biotherapeutics, Inc. | 2.88B | -1.71% | 148,288 | 376.07M |
| 199 | SUPN | Supernus Pharmaceuticals, Inc. | 2.88B | -1.03% | 86,449 | 718.95M |
| 200 | ORKA | Oruka Therapeutics, Inc. | 2.83B | 1.30% | 416,482 | - |
| 201 | VERA | Vera Therapeutics, Inc. | 2.81B | -2.56% | 313,913 | - |
| 202 | PRVA | Privia Health Group, Inc. | 2.78B | 2.64% | 190,726 | 2.12B |
| 203 | TXG | 10x Genomics, Inc. | 2.77B | -1.10% | 754,388 | 642.82M |
| 204 | HAE | Haemonetics Corporation | 2.76B | 1.73% | 79,382 | 1.32B |
| 205 | CON | Concentra Group Holdings Parent, Inc. | 2.75B | 2.00% | 202,009 | 2.16B |
| 206 | TNGX | Tango Therapeutics, Inc. | 2.75B | -5.03% | 437,317 | 62.38M |
| 207 | IDYA | IDEAYA Biosciences, Inc. | 2.73B | -3.99% | 344,496 | 218.71M |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.72B | -2.34% | 171,432 | 247.00M |
| 209 | SLNO | Soleno Therapeutics, Inc. | 2.70B | 0.06% | 8,991,900 | 190.41M |
| 210 | ALMS | Alumis Inc. | 2.69B | -3.69% | 387,597 | 24.05M |
| 211 | PBH | Prestige Consumer Healthcare Inc. | 2.62B | 0.36% | 99,386 | 1.10B |
| 212 | NHC | National HealthCare Corporation | 2.58B | 1.12% | 48,889 | 1.52B |
| 213 | VCYT | Veracyte, Inc. | 2.54B | -1.11% | 124,858 | 517.15M |
| 214 | KOD | Kodiak Sciences Inc. | 2.53B | 5.13% | 337,481 | - |
| 215 | WRBY | Warby Parker Inc. | 2.51B | -2.47% | 378,942 | 871.91M |
| 216 | LMAT | LeMaitre Vascular, Inc. | 2.50B | 0.65% | 64,147 | 249.60M |
| 217 | LFST | LifeStance Health Group, Inc. | 2.50B | 0.31% | 412,775 | 1.42B |
| 218 | HCM | HUTCHMED (China) Limited | 2.49B | -1.51% | 5,041 | 548.51M |
| 219 | IRON | Disc Medicine, Inc. | 2.48B | -1.11% | 94,057 | - |
| 220 | AAPG | Ascentage Pharma Group International | 2.44B | 0.36% | 1,036 | 82.08M |
| 221 | ELVN | Enliven Therapeutics, Inc. | 2.44B | 4.75% | 1,207,784 | - |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.44B | 0.18% | 112,561 | 1.45B |
| 223 | CLDX | Celldex Therapeutics, Inc. | 2.39B | -0.80% | 212,543 | 1.55M |
| 224 | IMNM | Immunome, Inc. | 2.36B | -2.70% | 315,774 | 6.94M |
| 225 | BEAM | Beam Therapeutics Inc. | 2.35B | -2.52% | 484,418 | 139.74M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.34B | -1.27% | 890,485 | 874.84M |
| 227 | SRPT | Sarepta Therapeutics, Inc. | 2.33B | -2.54% | 519,314 | 2.20B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.31B | 0.68% | 635,218 | 3.31B |
| 229 | ZLAB | Zai Lab Limited | 2.31B | -0.12% | 111,792 | 460.16M |
| 230 | RLAY | Relay Therapeutics, Inc. | 2.31B | 3.61% | 1,665,213 | 15.36M |
| 231 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | -1.66% | 494,574 | - |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.29B | -1.55% | 902,628 | 3.68B |
| 233 | MANE | Veradermics, Incorporated | 2.29B | -4.07% | 70,998 | - |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.22B | -0.96% | 411,052 | 673.00M |
| 235 | HTFL | HeartFlow, Inc. | 2.22B | -0.46% | 303,145 | 176.03M |
| 236 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.07% | 510,998 | 158.18M |
| 237 | ADMA | ADMA Biologics, Inc. | 2.21B | 0.22% | 915,163 | 510.17M |
| 238 | PAHC | Phibro Animal Health Corporation | 2.19B | -1.46% | 70,828 | 1.46B |
| 239 | NEOG | Neogen Corporation | 2.16B | 3.87% | 1,170,435 | 880.32M |
| 240 | NKTR | Nektar Therapeutics | 2.15B | 0.44% | 180,911 | 55.23M |
| 241 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | 0.12% | 312,504 | 172.35M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -1.62% | 363,274 | 283.06M |
| 243 | ADPT | Adaptive Biotechnologies Corporation | 2.06B | -4.83% | 367,759 | 276.98M |
| 244 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | -0.49% | 179,327 | 54.03M |
| 245 | SEM | Select Medical Holdings Corporation | 2.03B | -0.18% | 197,834 | 5.45B |
| 246 | TYRA | Tyra Biosciences, Inc. | 2.00B | -4.47% | 289,676 | - |
| 247 | DFTX | Definium Therapeutics, Inc. | 2.00B | -1.86% | 420,136 | - |
| 248 | STOK | Stoke Therapeutics, Inc. | 1.96B | 0.95% | 157,379 | 184.42M |
| 249 | GRAL | GRAIL, Inc. | 1.96B | -7.81% | 486,088 | 147.17M |
| 250 | GLPG | Galapagos NV | 1.95B | -3.45% | 162,422 | 1.31B |
| 251 | BHC | Bausch Health Companies Inc. | 1.93B | -3.51% | 375,455 | 10.27B |
| 252 | WGS | GeneDx Holdings Corp. | 1.93B | -1.29% | 236,107 | 427.54M |
| 253 | AHG | Akso Health Group | 1.91B | -1.11% | 180,608 | 14.84M |
| 254 | ZYME | Zymeworks Inc. | 1.87B | -1.86% | 130,904 | 105.97M |
| 255 | PHVS | Pharvaris N.V. | 1.80B | -2.84% | 69,381 | - |
| 256 | MESO | Mesoblast Limited | 1.77B | -9.48% | 232,628 | 65.38M |
| 257 | ANAB | AnaptysBio, Inc. | 1.76B | -1.86% | 67,606 | 234.60M |
| 258 | CAPR | Capricor Therapeutics, Inc. | 1.76B | -3.50% | 220,955 | 11.13M |
| 259 | OCUL | Ocular Therapeutix, Inc. | 1.76B | -0.06% | 1,205,343 | 51.95M |
| 260 | MD | Pediatrix Medical Group, Inc. | 1.75B | -0.32% | 176,405 | 1.91B |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.75B | -1.08% | 73,089 | 211.08M |
| 262 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.74B | -0.27% | 631,138 | -665.00K |
| 263 | VCEL | Vericel Corporation | 1.71B | -1.38% | 95,456 | 276.26M |
| 264 | INVA | Innoviva, Inc. | 1.70B | -0.09% | 137,622 | 411.33M |
| 265 | ADUS | Addus HomeCare Corporation | 1.69B | -0.47% | 84,967 | 1.42B |
| 266 | ATEC | Alphatec Holdings, Inc. | 1.69B | 1.55% | 526,429 | 764.16M |
| 267 | AORT | Artivion, Inc. | 1.67B | 2.75% | 368,054 | 441.33M |
| 268 | RXRX | Recursion Pharmaceuticals, Inc. | 1.66B | -0.48% | 3,863,943 | 74.68M |
| 269 | NRIX | Nurix Therapeutics, Inc. | 1.66B | 1.39% | 686,603 | 83.98M |
| 270 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | 2.25% | 76,071 | 883.37M |
| 271 | PVLA | Palvella Therapeutics, Inc. | 1.65B | -4.05% | 59,099 | - |
| 272 | AHCO | AdaptHealth Corp. | 1.63B | -0.91% | 189,943 | 3.24B |
| 273 | TRVI | Trevi Therapeutics, Inc. | 1.62B | -1.33% | 463,362 | - |
| 274 | AXGN | Axogen, Inc. | 1.60B | -5.30% | 349,586 | 225.21M |
| 275 | IMCR | Immunocore Holdings plc | 1.60B | -1.03% | 129,552 | 400.02M |
| 276 | INSP | Inspire Medical Systems, Inc. | 1.60B | 2.53% | 301,970 | 911.98M |
| 277 | SION | Sionna Therapeutics, Inc. | 1.60B | -4.98% | 139,670 | - |
| 278 | HRMY | Harmony Biosciences Holdings, Inc. | 1.59B | -0.63% | 151,046 | 868.45M |
| 279 | SGRY | Surgery Partners, Inc. | 1.59B | 0.73% | 278,382 | 3.31B |
| 280 | OGN | Organon & Co. | 1.58B | 0.25% | 795,440 | 6.22B |
| 281 | GENB | Generate Biomedicines, Inc. | 1.58B | 2.31% | 80,937 | 31.89M |
| 282 | OMCL | Omnicell, Inc. | 1.54B | -0.73% | 52,894 | 1.18B |
| 283 | DMRA | Damora Therapeutics, Inc. | 1.54B | 3.62% | 47,699 | - |
| 284 | OCS | Oculis Holding AG | 1.53B | -1.59% | 94,955 | 1.51M |
| 285 | NBTX | Nanobiotix S.A. | 1.53B | -9.68% | 44,805 | 38.27M |
| 286 | RAPP | Rapport Therapeutics, Inc. | 1.53B | -1.17% | 133,212 | - |
| 287 | NTLA | Intellia Therapeutics, Inc. | 1.53B | -2.78% | 766,064 | 67.67M |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.52B | 0.09% | 122,640 | 336.39M |
| 289 | PRGO | Perrigo Company plc | 1.50B | 3.21% | 3,549,355 | 4.25B |
| 290 | NUVB | Nuvation Bio Inc. | 1.48B | -3.15% | 763,906 | 62.90M |
| 291 | UFPT | UFP Technologies, Inc. | 1.47B | -0.53% | 98,381 | 602.80M |
| 292 | VRDN | Viridian Therapeutics, Inc. | 1.47B | 3.24% | 2,699,978 | 70.85M |
| 293 | ATRC | AtriCure, Inc. | 1.45B | -0.45% | 90,456 | 534.53M |
| 294 | ARDX | Ardelyx, Inc. | 1.43B | -2.09% | 797,954 | 407.32M |
| 295 | SVRA | Savara Inc. | 1.42B | -0.18% | 475,217 | - |
| 296 | MBX | MBX Biosciences, Inc. | 1.41B | -4.92% | 946,286 | - |
| 297 | VIR | Vir Biotechnology, Inc. | 1.41B | -2.65% | 628,758 | 68.56M |
| 298 | AVAH | Aveanna Healthcare Holdings Inc. | 1.41B | -0.31% | 204,277 | 2.43B |
| 299 | PGEN | Precigen, Inc. | 1.41B | -5.13% | 1,248,176 | 9.68M |
| 300 | BCAX | Bicara Therapeutics Inc. | 1.40B | 2.54% | 205,148 | - |
| 301 | MAZE | Maze Therapeutics, Inc. | 1.39B | -3.45% | 196,777 | 2.50M |
| 302 | BHVN | Biohaven Ltd. | 1.36B | -0.98% | 416,841 | - |
| 303 | ASTH | Astrana Health, Inc. | 1.36B | 5.77% | 178,972 | 3.18B |
| 304 | IOVA | Iovance Biotherapeutics, Inc. | 1.36B | - | 3,542,925 | 263.50M |
| 305 | ATAI | AtaiBeckley Inc. | 1.34B | -4.42% | 1,191,570 | 4.09M |
| 306 | IMTX | Immatics N.V. | 1.34B | -3.01% | 120,390 | 56.67M |
| 307 | PGNY | Progyny, Inc. | 1.33B | 0.89% | 337,712 | 1.29B |
| 308 | PRCT | PROCEPT BioRobotics Corporation | 1.32B | -1.26% | 306,801 | 308.05M |
| 309 | GLUE | Monte Rosa Therapeutics, Inc. | 1.32B | -2.30% | 126,055 | 123.67M |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.32B | 0.21% | 125,127 | 1.84B |
| 311 | TNDM | Tandem Diabetes Care, Inc. | 1.31B | -0.16% | 563,539 | 1.01B |
| 312 | PLSE | Pulse Biosciences, Inc. | 1.31B | -16.13% | 145,141 | 350.00K |
| 313 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -1.32% | 236,526 | - |
| 314 | ZBIO | Zenas BioPharma, Inc. | 1.30B | -1.75% | 119,618 | 10.00M |
| 315 | WVE | Wave Life Sciences Ltd. | 1.29B | -3.17% | 705,217 | 42.73M |
| 316 | ARDT | Ardent Health, Inc. | 1.29B | 1.01% | 37,653 | 6.32B |
| 317 | ENOV | Enovis Corporation | 1.29B | -1.05% | 156,785 | 2.25B |
| 318 | HROW | Harrow, Inc. | 1.29B | -1.57% | 123,964 | 272.30M |
| 319 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | -3.66% | 442,489 | 9.77M |
| 320 | NVAX | Novavax, Inc. | 1.27B | -2.01% | 785,894 | 1.12B |
| 321 | MLTX | MoonLake Immunotherapeutics | 1.22B | - | 278,860 | - |
| 322 | IRMD | IRADIMED CORPORATION | 1.21B | -0.85% | 33,355 | 83.81M |
| 323 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -3.33% | 234,776 | - |
| 324 | NVCR | NovoCure Limited | 1.18B | -1.90% | 205,206 | 655.35M |
| 325 | DBVT | DBV Technologies S.A. | 1.17B | -0.59% | 68,243 | 5.64M |
| 326 | NNNN | Anbio Biotechnology | 1.16B | 1.36% | 9,077 | 6.92M |
| 327 | PHAR | Pharming Group N.V. | 1.16B | -1.21% | 3,207 | 376.13M |
| 328 | GERN | Geron Corporation | 1.13B | 0.57% | 6,258,942 | 183.88M |
| 329 | ALVO | Alvotech | 1.12B | -5.41% | 134,560 | 588.90M |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.11B | -0.50% | 19,647 | 773.34M |
| 331 | SEPN | Septerna, Inc. | 1.10B | -1.57% | 40,348 | 45.95M |
| 332 | KMTS | Kestra Medical Technologies, Ltd. | 1.09B | -3.47% | 45,255 | 83.72M |
| 333 | EYPT | EyePoint, Inc. | 1.08B | -0.95% | 266,595 | 31.37M |
| 334 | AVBP | ArriVent BioPharma, Inc. | 1.08B | -2.36% | 40,154 | - |
| 335 | INNV | InnovAge Holding Corp. | 1.07B | -1.00% | 76,727 | 915.37M |
| 336 | QURE | uniQure N.V. | 1.06B | -2.13% | 360,328 | 16.10M |
| 337 | STAA | STAAR Surgical Company | 1.06B | 2.15% | 289,721 | 239.44M |
| 338 | PNTG | The Pennant Group, Inc. | 1.05B | 0.70% | 67,657 | 947.71M |
| 339 | CNMD | CONMED Corporation | 1.05B | -0.18% | 88,108 | 1.37B |
| 340 | IVA | Inventiva S.A. | 1.04B | -6.35% | 130,756 | 9.31M |
| 341 | COLL | Collegium Pharmaceutical, Inc. | 1.04B | 0.14% | 93,353 | 780.57M |
| 342 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -0.83% | 418,042 | 291.85M |
| 343 | NEO | NeoGenomics, Inc. | 1.03B | -1.37% | 541,323 | 727.33M |
| 344 | KALV | KalVista Pharmaceuticals, Inc. | 1.03B | -0.82% | 652,823 | 73.62M |
| 345 | QDEL | QuidelOrtho Corporation | 1.03B | -5.16% | 525,242 | 2.73B |
| 346 | BFLY | Butterfly Network, Inc. | 1.02B | -2.91% | 982,592 | 97.61M |
| 347 | CLOV | Clover Health Investments, Corp. | 1.02B | 3.74% | 3,051,631 | 1.92B |
| 348 | SSII | SS Innovations International, Inc. | 995.70M | 3.53% | 12,912 | 42.48M |
| 349 | AZTA | Azenta, Inc. | 991.24M | -4.74% | 226,827 | 595.03M |
| 350 | ABCL | AbCellera Biologics Inc. | 988.30M | -3.83% | 1,704,181 | 75.13M |
| 351 | MPLT | MapLight Therapeutics, Inc. | 986.58M | -0.88% | 53,763 | - |
| 352 | CRON | Cronos Group Inc. | 980.38M | -2.33% | 248,609 | 146.59M |
| 353 | CMPX | Compass Therapeutics, Inc. | 943.66M | -4.55% | 642,847 | 850.00K |
| 354 | TDOC | Teladoc Health, Inc. | 931.23M | -1.88% | 1,101,021 | 2.53B |
| 355 | AMPH | Amphastar Pharmaceuticals, Inc. | 922.38M | -1.21% | 134,747 | 719.89M |
| 356 | EVO | Evotec SE | 921.82M | -1.91% | 255,132 | 887.40M |
| 357 | ANNX | Annexon, Inc. | 919.52M | -1.21% | 645,861 | - |
| 358 | AKTS | Aktis Oncology, Inc. | 918.69M | 1.53% | 164,633 | 6.50M |
| 359 | CTMX | CytomX Therapeutics, Inc. | 910.11M | -4.32% | 1,320,732 | 76.20M |
| 360 | GHRS | GH Research PLC | 908.73M | -3.24% | 38,943 | - |
| 361 | PCRX | Pacira BioSciences, Inc. | 903.73M | 0.22% | 103,266 | 726.41M |
| 362 | BLFS | BioLife Solutions, Inc. | 899.83M | -3.32% | 66,937 | 96.21M |
| 363 | EVMN | Evommune, Inc. | 896.14M | 1.22% | 155,657 | 13.00M |
| 364 | OPK | OPKO Health, Inc. | 895.70M | - | 410,857 | 606.88M |
| 365 | JANX | Janux Therapeutics, Inc. | 893.01M | -1.74% | 206,442 | 10.00M |
| 366 | CDNA | CareDx, Inc. | 891.68M | -2.30% | 132,145 | 379.81M |
| 367 | ORIC | ORIC Pharmaceuticals, Inc. | 889.17M | -0.56% | 377,295 | - |
| 368 | INBX | Inhibrx Biosciences, Inc. | 882.70M | -5.16% | 65,450 | 1.30M |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 880.66M | -2.48% | 156,768 | - |
| 370 | XNCR | Xencor, Inc. | 880.06M | -3.54% | 146,200 | 125.58M |
| 371 | PHAT | Phathom Pharmaceuticals, Inc. | 879.39M | -0.80% | 349,168 | 175.11M |
| 372 | URGN | UroGen Pharma Ltd. | 871.90M | -3.76% | 192,721 | 109.79M |
| 373 | INMD | InMode Ltd. | 866.11M | -0.29% | 315,922 | 370.50M |
| 374 | FTRE | Fortrea Holdings Inc. | 864.88M | 2.66% | 309,339 | 2.72B |
| 375 | TALK | Talkspace, Inc. | 863.78M | -0.58% | 2,321,669 | 228.87M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 861.14M | 0.22% | 162,866 | 1.02B |
| 377 | ABUS | Arbutus Biopharma Corporation | 859.13M | -1.46% | 284,332 | 14.08M |
| 378 | TBPH | Theravance Biopharma, Inc. | 843.45M | 1.74% | 147,289 | 107.46M |
| 379 | CERT | Certara, Inc. | 835.62M | -0.18% | 751,701 | 418.84M |
| 380 | SDGR | Schrödinger, Inc. | 822.78M | -3.26% | 294,054 | 255.87M |
| 381 | SPRY | ARS Pharmaceuticals, Inc. | 812.25M | -2.50% | 324,946 | 84.28M |
| 382 | SANA | Sana Biotechnology, Inc. | 811.28M | -5.59% | 848,637 | - |
| 383 | VOR | Vor Biopharma Inc. | 803.57M | -8.85% | 861,819 | - |
| 384 | SLS | SELLAS Life Sciences Group, Inc. | 799.14M | -1.77% | 1,305,527 | - |
| 385 | MNKD | MannKind Corporation | 773.33M | -1.95% | 1,004,739 | 348.97M |
| 386 | JBIO | Jade Biosciences, Inc. | 771.31M | -3.28% | 123,598 | - |
| 387 | BIOA | BioAge Labs, Inc. | 768.21M | -1.25% | 99,443 | 9.00M |
| 388 | OMER | Omeros Corporation | 754.52M | -3.72% | 492,573 | - |
| 389 | TLRY | Tilray Brands, Inc. | 753.80M | -2.85% | 893,481 | 858.28M |
| 390 | MGTX | MeiraGTx Holdings plc | 748.90M | -3.41% | 201,451 | 81.39M |
| 391 | KURA | Kura Oncology, Inc. | 741.97M | -1.06% | 222,909 | 67.48M |
| 392 | OMDA | Omada Health, Inc. | 741.28M | - | 128,990 | 260.21M |
| 393 | DSGN | Design Therapeutics, Inc. | 738.22M | -4.47% | 181,543 | - |
| 394 | TENX | Tenax Therapeutics, Inc. | 737.40M | -1.48% | 92,113 | - |
| 395 | SLDB | Solid Biosciences Inc. | 736.95M | -3.23% | 289,320 | - |
| 396 | CSTL | Castle Biosciences, Inc. | 735.55M | 0.04% | 54,053 | 344.23M |
| 397 | MRVI | Maravai LifeSciences Holdings, Inc. | 735.21M | -3.05% | 755,543 | 185.74M |
| 398 | DRUG | Bright Minds Biosciences Inc. | 732.20M | -0.59% | 28,321 | - |
| 399 | BVS | Bioventus Inc. | 726.77M | -3.10% | 291,371 | 568.09M |
| 400 | IART | Integra LifeSciences Holdings Corporation | 723.26M | -0.32% | 176,710 | 1.64B |
| 401 | AMN | AMN Healthcare Services, Inc. | 720.17M | 0.38% | 192,850 | 2.73B |
| 402 | ARVN | Arvinas, Inc. | 710.93M | -0.94% | 195,159 | 262.60M |
| 403 | EHAB | Enhabit, Inc. | 709.87M | 0.18% | 297,988 | 1.06B |
| 404 | GDRX | GoodRx Holdings, Inc. | 705.70M | -0.48% | 270,820 | 796.85M |
| 405 | CMPS | COMPASS Pathways plc | 702.63M | -5.22% | 547,862 | - |
| 406 | NUTX | Nutex Health Inc. | 694.81M | -0.93% | 91,763 | 875.26M |
| 407 | RLMD | Relmada Therapeutics, Inc. | 694.36M | -4.06% | 248,471 | - |
| 408 | SGP | SpyGlass Pharma, Inc. | 690.59M | -8.79% | 26,013 | - |
| 409 | ETON | Eton Pharmaceuticals, Inc. | 678.29M | -0.56% | 103,971 | 79.95M |
| 410 | ANRO | Alto Neuroscience, Inc. | 675.69M | -6.12% | 72,413 | - |
| 411 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | - | 603,692 | 49.80M |
| 412 | CBLL | CeriBell, Inc. | 666.63M | -2.53% | 91,909 | 89.06M |
| 413 | REPL | Replimune Group, Inc. | 659.76M | -6.44% | 1,098,489 | - |
| 414 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 652.27M | -8.53% | 92,667 | - |
| 415 | LBRX | LB Pharmaceuticals Inc | 640.57M | -6.01% | 114,560 | - |
| 416 | GYRE | Gyre Therapeutics, Inc. | 639.20M | -1.69% | 24,084 | 116.59M |
| 417 | AVNS | Avanos Medical, Inc. | 632.97M | -1.59% | 76,156 | 701.20M |
| 418 | PSNL | Personalis, Inc. | 631.73M | -8.28% | 748,050 | 69.65M |
| 419 | CBIO | Crescent Biopharma, Inc. | 618.77M | -3.87% | 58,237 | 10.84M |
| 420 | ALLO | Allogene Therapeutics, Inc. | 617.98M | -2.50% | 1,470,643 | 22.00K |
| 421 | DRTS | Alpha Tau Medical Ltd. | 616.07M | 2.49% | 97,804 | - |
| 422 | HSTM | HealthStream, Inc. | 605.92M | 1.18% | 33,392 | 304.06M |
| 423 | MDXG | MiMedx Group, Inc. | 582.38M | 1.03% | 182,532 | 418.63M |
| 424 | CTKB | Cytek Biosciences, Inc. | 582.33M | 0.22% | 147,312 | 201.49M |
| 425 | SIBN | SI-BONE, Inc. | 578.57M | -0.83% | 204,147 | 200.93M |
| 426 | ESPR | Esperion Therapeutics, Inc. | 577.82M | -11.76% | 3,935,655 | 403.14M |
| 427 | PRME | Prime Medicine, Inc. | 572.85M | -3.14% | 666,295 | 4.63M |
| 428 | OCGN | Ocugen, Inc. | 571.05M | -4.52% | 2,215,306 | 4.41M |
| 429 | CRMD | CorMedix Inc. | 560.47M | 0.14% | 231,619 | 311.71M |
| 430 | TCMD | Tactile Systems Technology, Inc. | 555.11M | -0.69% | 67,638 | 329.52M |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 554.82M | -2.98% | 186,977 | 106.47M |
| 432 | PROK | ProKidney Corp. | 554.02M | 1.38% | 324,403 | 893.00K |
| 433 | IRWD | Ironwood Pharmaceuticals, Inc. | 552.77M | -3.97% | 405,535 | 296.15M |
| 434 | ZURA | Zura Bio Limited | 549.36M | -4.46% | 178,245 | - |
| 435 | PHR | Phreesia, Inc. | 549.30M | -1.20% | 744,926 | 480.59M |
| 436 | BWAY | BrainsWay Ltd. | 544.09M | -2.62% | 79,744 | 52.23M |
| 437 | VALN | Valneva SE | 543.61M | -1.34% | 45,284 | 205.07M |
| 438 | KYTX | Kyverna Therapeutics, Inc. | 541.98M | -0.17% | 177,775 | - |
| 439 | TECX | Tectonic Therapeutic, Inc. | 537.95M | -4.44% | 109,118 | - |
| 440 | PRTA | Prothena Corporation plc | 536.71M | -0.70% | 142,365 | 9.68M |
| 441 | EMBC | Embecta Corp. | 524.69M | -0.78% | 111,878 | 1.08B |
| 442 | AGMB | AgomAb Therapeutics NV | 521.00M | -8.63% | 74,465 | - |
| 443 | UPB | Upstream Bio, Inc. | 514.81M | -2.67% | 86,343 | 2.85M |
| 444 | ACRS | Aclaris Therapeutics, Inc. | 512.20M | -3.03% | 390,714 | 7.83M |
| 445 | LRMR | Larimar Therapeutics, Inc. | 508.51M | -3.07% | 297,861 | - |
| 446 | AVR | Anteris Technologies Global Corp. | 507.64M | -0.78% | 287,145 | 1.91M |
| 447 | FULC | Fulcrum Therapeutics, Inc. | 505.83M | -3.00% | 360,207 | 80.00M |
| 448 | FDMT | 4D Molecular Therapeutics, Inc. | 505.41M | -0.40% | 319,959 | 85.21M |
| 449 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 450 | RIGL | Rigel Pharmaceuticals, Inc. | 503.21M | -0.44% | 78,175 | 294.28M |
| 451 | LYEL | Lyell Immunopharma, Inc. | 503.19M | -0.55% | 35,425 | 36.00K |
| 452 | FBRX | Forte Biosciences, Inc. | 500.17M | 0.79% | 66,013 | - |
| 453 | ENGN | enGene Holdings Inc. | 495.05M | 2.07% | 117,482 | - |
| 454 | AQST | Aquestive Therapeutics, Inc. | 489.40M | -1.96% | 473,088 | 44.55M |
| 455 | CTNM | Contineum Therapeutics, Inc. | 489.10M | -2.53% | 49,777 | - |
| 456 | CATX | Perspective Therapeutics, Inc. | 488.20M | -2.17% | 187,082 | 884.00K |
| 457 | EIKN | Eikon Therapeutics, Inc. | 487.25M | -4.66% | 126,141 | - |
| 458 | TRDA | Entrada Therapeutics, Inc. | 487.08M | -2.52% | 29,809 | 25.42M |
| 459 | NPCE | NeuroPace, Inc. | 482.11M | -1.92% | 20,846 | 99.99M |
| 460 | YDES | YD Bio Limited | 480.99M | -3.97% | 4,816 | 510.36K |
| 461 | KMDA | Kamada Ltd. | 476.75M | -1.03% | 7,389 | 180.46M |
| 462 | STTK | Shattuck Labs, Inc. | 470.18M | -3.10% | 99,318 | 1.00M |
| 463 | OFIX | Orthofix Medical Inc. | 468.89M | -0.76% | 57,275 | 822.31M |
| 464 | AVIR | Atea Pharmaceuticals, Inc. | 466.48M | -0.26% | 79,668 | - |
| 465 | VSTM | Verastem, Inc. | 462.01M | -4.01% | 348,726 | 30.91M |
| 466 | FLGT | Fulgent Genetics, Inc. | 460.36M | -2.80% | 62,425 | 322.67M |
| 467 | ADCT | ADC Therapeutics SA | 457.99M | -1.77% | 255,944 | 81.36M |
| 468 | ASMB | Assembly Biosciences, Inc. | 453.04M | -2.26% | 26,991 | 72.30M |
| 469 | VTVT | vTv Therapeutics Inc. | 451.46M | -7.99% | 54,291 | 17.00K |
| 470 | RGNX | REGENXBIO Inc. | 441.33M | -2.84% | 129,669 | 170.44M |
| 471 | IMMX | Immix Biopharma, Inc. | 440.67M | -3.14% | 262,970 | - |
| 472 | VREX | Varex Imaging Corporation | 439.32M | -0.76% | 53,842 | 854.40M |
| 473 | ALT | Altimmune, Inc. | 438.45M | 1.20% | 788,870 | 41.00K |
| 474 | LXEO | Lexeo Therapeutics, Inc. | 437.11M | 2.25% | 298,133 | - |
| 475 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.01M | -4.51% | 65,579 | - |
| 476 | MYGN | Myriad Genetics, Inc. | 433.88M | -0.64% | 411,542 | 824.50M |
| 477 | PACB | Pacific Biosciences of California, Inc. | 433.37M | 1.06% | 1,923,175 | 160.01M |
| 478 | ABSI | Absci Corporation | 431.52M | -4.73% | 1,595,740 | 2.80M |
| 479 | BBNX | Beta Bionics, Inc. | 430.95M | -2.41% | 159,878 | 100.25M |
| 480 | AUNA | Auna S.A. | 425.57M | -1.54% | 26,013 | 1.30B |
| 481 | AURA | Aura Biosciences, Inc. | 419.54M | -2.10% | 163,865 | - |
| 482 | VNDA | Vanda Pharmaceuticals Inc. | 418.96M | 1.69% | 450,280 | 216.11M |
| 483 | ARMP | Armata Pharmaceuticals, Inc. | 416.88M | 7.87% | 56,276 | 4.90M |
| 484 | STRO | Sutro Biopharma, Inc. | 411.03M | 3.59% | 66,555 | 102.48M |
| 485 | XOMA | XOMA Royalty Corporation | 408.23M | 1.51% | 68,896 | 52.15M |
| 486 | IPSC | Century Therapeutics, Inc. | 407.97M | 3.65% | 980,128 | 109.16M |
| 487 | CYH | Community Health Systems, Inc. | 404.27M | 1.68% | 398,170 | 12.49B |
| 488 | WEAV | Weave Communications, Inc. | 403.86M | 1.08% | 315,200 | 239.02M |
| 489 | EBS | Emergent BioSolutions Inc. | 401.28M | -4.07% | 191,302 | 742.90M |
| 490 | ANGO | AngioDynamics, Inc. | 397.02M | -3.20% | 221,111 | 313.73M |
| 491 | KIDS | OrthoPediatrics Corp. | 396.37M | -1.63% | 23,192 | 236.35M |
| 492 | NAUT | Nautilus Biotechnology, Inc. | 389.82M | -8.06% | 176,189 | - |
| 493 | NRC | National Research Corporation | 388.28M | -1.50% | 18,536 | 137.39M |
| 494 | CGC | Canopy Growth Corporation | 383.04M | -3.79% | 2,166,133 | 203.04M |
| 495 | ENTA | Enanta Pharmaceuticals, Inc. | 374.93M | -2.49% | 26,439 | 66.98M |
| 496 | NMRA | Neumora Therapeutics, Inc. | 374.09M | -3.07% | 343,314 | - |
| 497 | LCTX | Lineage Cell Therapeutics, Inc. | 373.63M | -2.60% | 393,720 | 14.56M |
| 498 | VMD | Viemed Healthcare, Inc. | 372.04M | -1.25% | 45,542 | 270.28M |
| 499 | DNA | Ginkgo Bioworks Holdings, Inc. | 370.20M | -7.42% | 285,348 | 170.16M |
| 500 | BNTC | Benitec Biopharma Inc. | 369.95M | -1.73% | 14,390 | - |